Climb Bio, Inc. (CLYM)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
|
CEO, President & Director | 1.09M | -- | 1976 |
|
Dr. Susan Altschuller M.B.A., Ph.D.
|
CFO & Principal Accounting Officer | 570.81k | -- | 1982 |
|
Dr. Perrin Wilson B.S., Ph.D.
|
Chief Business Officer | 793.42k | -- | 1979 |
|
Mr. Adam Villa
|
Senior Vice President of Technical Operations | -- | -- | -- |
|
Ms. Chandra Adams J.D.
|
Senior VP, General Counsel & Secretary | -- | -- | -- |
|
Ms. Ashley Jones
|
Senior Vice President of People & Workforce Strategy | -- | -- | -- |
|
Dr. Edgar D. Charles M.D., M.Sc.
|
Chief Medical Officer | -- | -- | -- |
Climb Bio, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 28
Description
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases. The company's lead product candidate is the budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug which is in phase 2 clinical trials for the treatment of primary membranous nephropathy and immune thrombocytopenia; and Phase 1b clinical trial indicated for the systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN) and other B-cell mediated diseases. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.
Corporate Governance
Upcoming Events
November 13, 2026 at 1:30 PM UTC
Climb Bio, Inc. Earnings Date
Recent Events
June 5, 2026 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
